Recruiting IBS Studies in South Miami
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C wh...
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
This is a randomized, double-blind, placebo-controlled dose-ranging study to assess the safety and efficacy of tenapanor for treatment of the IBS-C in pediatric patients 6 to less than 12 year old....
About IBS Clinical Trials in South Miami
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder causing abdominal pain, bloating, and altered bowel habits. It affects 10-15% of the global population. Management includes dietary changes (low FODMAP diet), stress management, and medications targeting specific symptoms.
There are currently 2 ibs clinical trials recruiting participants in South Miami, FL. These studies are seeking a combined 252 participants. Research is being sponsored by Ardelyx. Clinical trial participation is free and participants receive study-related medical care at no cost.
IBS Clinical Trials in South Miami — FAQ
Are there ibs clinical trials in South Miami?
Yes, there are 2 ibs clinical trials currently recruiting in South Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in South Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the South Miami research site will contact you about next steps.
Are clinical trials in South Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many South Miami studies also compensate for your time and travel.
What ibs treatments are being tested?
The 2 active trials in South Miami are testing new therapies including novel drugs, biologics, and treatment approaches for ibs.
Data updated March 2, 2026 from ClinicalTrials.gov